Cargando…
Natalizumab for GVHD: too little or too late?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505719/ https://www.ncbi.nlm.nih.gov/pubmed/37698891 http://dx.doi.org/10.1182/bloodadvances.2023010486 |
| _version_ | 1785106962903465984 |
|---|---|
| author | Quann, Kevin Sacirbegovic, Faruk Shlomchik, Warren D. |
| author_facet | Quann, Kevin Sacirbegovic, Faruk Shlomchik, Warren D. |
| author_sort | Quann, Kevin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10505719 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105057192023-09-19 Natalizumab for GVHD: too little or too late? Quann, Kevin Sacirbegovic, Faruk Shlomchik, Warren D. Blood Adv Inside Blood Advances The American Society of Hematology 2023-09-12 /pmc/articles/PMC10505719/ /pubmed/37698891 http://dx.doi.org/10.1182/bloodadvances.2023010486 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Inside Blood Advances Quann, Kevin Sacirbegovic, Faruk Shlomchik, Warren D. Natalizumab for GVHD: too little or too late? |
| title | Natalizumab for GVHD: too little or too late? |
| title_full | Natalizumab for GVHD: too little or too late? |
| title_fullStr | Natalizumab for GVHD: too little or too late? |
| title_full_unstemmed | Natalizumab for GVHD: too little or too late? |
| title_short | Natalizumab for GVHD: too little or too late? |
| title_sort | natalizumab for gvhd: too little or too late? |
| topic | Inside Blood Advances |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505719/ https://www.ncbi.nlm.nih.gov/pubmed/37698891 http://dx.doi.org/10.1182/bloodadvances.2023010486 |
| work_keys_str_mv | AT quannkevin natalizumabforgvhdtoolittleortoolate AT sacirbegovicfaruk natalizumabforgvhdtoolittleortoolate AT shlomchikwarrend natalizumabforgvhdtoolittleortoolate |